Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence

NCT02437344 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Opioid Dependence

Interventions

DRUG: CI-581aa
DRUG: Naltrexone titration and XR-NTX initiation

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]